Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

884 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peptide Nanosponges Designed for the Delivery of Perillyl Alcohol to Glioma Cells.
Yapa AS, Shrestha TB, Wendel SO, Kalubowilage M, Yu J, Wang H, Pyle M, Basel MT, Toledo Y, Ortega R, Malalasekera AP, Thapa PS, Troyer DL, Bossmann SH. Yapa AS, et al. Among authors: ortega r. ACS Appl Bio Mater. 2019 Jan 22;2(1):49-60. doi: 10.1021/acsabm.8b00305. Epub 2018 Dec 26. ACS Appl Bio Mater. 2019. PMID: 35016330
Rationally designed peptide nanosponges for cell-based cancer therapy.
Wang H, Yapa AS, Kariyawasam NL, Shrestha TB, Kalubowilage M, Wendel SO, Yu J, Pyle M, Basel MT, Malalasekera AP, Toledo Y, Ortega R, Thapa PS, Huang H, Sun SX, Smith PE, Troyer DL, Bossmann SH. Wang H, et al. Among authors: ortega r. Nanomedicine. 2017 Nov;13(8):2555-2564. doi: 10.1016/j.nano.2017.07.004. Epub 2017 Jul 25. Nanomedicine. 2017. PMID: 28754467
Peptide nanosponges designed for rapid uptake by leukocytes and neural stem cells.
Yapa AS, Wang H, Wendel SO, Shrestha TB, Kariyawasam NL, Kalubowilage M, Perera AS, Pyle M, Basel MT, Malalasekera AP, Manawadu H, Yu J, Toledo Y, Ortega R, Thapa PS, Smith PE, Troyer DL, Bossmann SH. Yapa AS, et al. Among authors: ortega r. RSC Adv. 2018 Apr 30;8(29):16052-16060. doi: 10.1039/c8ra00717a. eCollection 2018 Apr 27. RSC Adv. 2018. PMID: 35542227 Free PMC article.
Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection.
Udukala DN, Wang H, Wendel SO, Malalasekera AP, Samarakoon TN, Yapa AS, Abayaweera G, Basel MT, Maynez P, Ortega R, Toledo Y, Bossmann L, Robinson C, Janik KE, Koper OB, Li P, Motamedi M, Higgins DA, Gadbury G, Zhu G, Troyer DL, Bossmann SH. Udukala DN, et al. Among authors: ortega r. Beilstein J Nanotechnol. 2016 Mar 7;7:364-373. doi: 10.3762/bjnano.7.33. eCollection 2016. Beilstein J Nanotechnol. 2016. PMID: 27335730 Free PMC article.
A nanobiosensor for the detection of arginase activity.
Malalasekera AP, Wang H, Samarakoon TN, Udukala DN, Yapa AS, Ortega R, Shrestha TB, Alshetaiwi H, McLaurin EJ, Troyer DL, Bossmann SH. Malalasekera AP, et al. Among authors: ortega r. Nanomedicine. 2017 Feb;13(2):383-390. doi: 10.1016/j.nano.2016.08.014. Epub 2016 Aug 21. Nanomedicine. 2017. PMID: 27558349
Early detection of pancreatic cancers in liquid biopsies by ultrasensitive fluorescence nanobiosensors.
Kalubowilage M, Covarrubias-Zambrano O, Malalasekera AP, Wendel SO, Wang H, Yapa AS, Chlebanowski L, Toledo Y, Ortega R, Janik KE, Shrestha TB, Culbertson CT, Kasi A, Williamson S, Troyer DL, Bossmann SH. Kalubowilage M, et al. Among authors: ortega r. Nanomedicine. 2018 Aug;14(6):1823-1832. doi: 10.1016/j.nano.2018.04.020. Epub 2018 May 18. Nanomedicine. 2018. PMID: 29782949
Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes.
Miró Ò, Núñez J, Trullàs JC, Lopez-Ayala P, Llauger L, Alquézar-Arbé A, Miñana G, Mollar A, de la Espriella R, Lorenzo M, Jacob J, Espinosa B, Garcés-Horna V, Aguirre A, Fortuny MJ, Martínez-Nadal G, Gil V, Mueller C, Llorens P; ICA-SEMES; INCLIVA; ALCALOTIC research groups. Miró Ò, et al. Eur J Intern Med. 2024 May 18:S0953-6205(24)00213-9. doi: 10.1016/j.ejim.2024.05.009. Online ahead of print. Eur J Intern Med. 2024. PMID: 38763846
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Cocozaki A, Chuong EB, Bitler BG. Nguyen LL, et al. Among authors: ortega r. Mol Cancer Ther. 2024 May 8. doi: 10.1158/1535-7163.MCT-23-0613. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38714351
NP3 MS Workflow: An Open-Source Software System to Empower Natural Product-Based Drug Discovery Using Untargeted Metabolomics.
Bazzano CF, de Felicio R, Alves LFG, Costa JH, Ortega R, Vieira BD, Morais-Urano RP, Furtado LC, Ferreira ELF, Gubiani JR, Berlinck RGS, Costa-Lotufo LV, Telles GP, B B Trivella D. Bazzano CF, et al. Among authors: ortega r. Anal Chem. 2024 May 14;96(19):7460-7469. doi: 10.1021/acs.analchem.3c05829. Epub 2024 May 3. Anal Chem. 2024. PMID: 38702053 Free PMC article.
Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival-a propensity score cohort study.
Fernandez-Gonzalez S, Falo C, Pla MJ, Campos M, Ortega-Exposito C, Ortega R, Vicente M, Petit A, Bosch-Schips J, Bajen MT, Reyes G, Martínez E, González-Viguera J, Peñafiel J, Stradella A, Pernas S, Ponce J, Garcia-Tejedor A. Fernandez-Gonzalez S, et al. Among authors: ortega r. Breast Cancer Res Treat. 2024 Apr 18. doi: 10.1007/s10549-024-07274-1. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38635082
884 results